The State of the Science Union

Written byIvan Oransky

| 1 min read

President Bush thinks that science is the key to keeping the US ahead. It will help the country wean itself off fossil fuels, he said in his fifth linkurl:State of the Union;http://www.whitehouse.gov/news/releases/2002/01/20020129-11.html last night, and it will keep the nation?s businesses competitive in the global marketplace. He wants to start with children, whom he?d like to see ?take more math and science and to make sure those courses are rigorous enough to compete with other nations.? Presumably, that leaves little room for intelligent design in science class, which he linkurl:nearly endorsed;http://www.the-scientist.com/blog/display/85/ several months ago? But before life scientists get too excited, it?s worth noting that according to his address, the physical sciences matter much more than the life sciences ? twice as much, in fact. Bush proposed doubling ?the federal commitment to the most critical basic research programs in the physical sciences over the next 10 years.? Such funding, he said, ?will support the work of America?s most creative minds as they explore promising areas such as nanotechnology and supercomputing and alternative energy sources.? Life scientists take note: you?re not America?s most creative minds; physicists, chemists, and engineers are. There were some suggestions that help was on the way for biology as well, at least on the corporate side. The president didn?t mention the NIH budget, which looks as though it will actually drop by $35 million this year. He did propose making the R&D tax credit permanent, ?to encourage bolder private-sector initiative in technology,? and that could certainly benefit biotech as much as it benefits other scientific industries. And he wants to keep spending on biodefense high. How all of this will play out in Congress is of course yet to be seen. Stay tuned.

The State of the Science Union

The Scientist ARCHIVES

Become a Member of

Meet the Author

Ivan Oransky

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform